Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7457)
All Articles published online
|
Publishing Process of This Article
|
Sep 8, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lanthier N. Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how? World J Hepatol 2015; 7(19): 2184-2188 [PMID: 26380042 DOI: 10.4254/wjh.v7.i19.2184] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i19/2184.htm |
| Number | Citing Articles |
| 1 |
Nicolas Lanthier, Peter Stärkel. Treatment of severe alcoholic hepatitis: past, present and future. European Journal of Clinical Investigation 2017; 47(7): 531 doi: 10.1111/eci.12767
|
| 2 |
Q Binet, A Loumaye, V Preumont, J-P Thissen, M.P. Hermans, N Lanthier. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?. Acta Gastro Enterologica Belgica 2022; 85(2): 346 doi: 10.51821/85.2.9775
|
| 3 |
Quentin Etienne, Valérie Lebrun, Mina Komuta, Benoît Navez, Jean-Paul Thissen, Isabelle A. Leclercq, Nicolas Lanthier. Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis. Metabolites 2022; 12(7): 625 doi: 10.3390/metabo12070625
|
| 4 |
Mengzhen Li, Faren Xie, Lu Wang, Guoxue Zhu, Lian-Wen Qi, Shujun Jiang. Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.857956
|
| 5 |
Jorge Gutiérrez-Cuevas, Arturo Santos, Juan Armendariz-Borunda. Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. International Journal of Molecular Sciences 2021; 22(21): 11629 doi: 10.3390/ijms222111629
|
| 6 |
Nicolas Lanthier, Valérie Lebrun, Olivier Molendi-Coste, Nico van Rooijen, Isabelle A. Leclercq. Liver Fetuin-A at Initiation of Insulin Resistance. Metabolites 2022; 12(11): 1023 doi: 10.3390/metabo12111023
|
| 7 |
Anna Alisi, Guido Carpino, Felipe L. Oliveira, Nadia Panera, Valerio Nobili, Eugenio Gaudio. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/8162421
|
| 8 |
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
|
| 9 |
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra. Molecular Pathogenesis of NASH. International Journal of Molecular Sciences 2016; 17(9): 1575 doi: 10.3390/ijms17091575
|
| 10 |
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, Evangelos Cholongitas. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World Journal of Gastroenterology 2022; 28(3): 310-331 doi: 10.3748/wjg.v28.i3.310
|
| 11 |
Lisanne L. Blauw, Zhuang Li, Sander S. Rensen, Jan Willem M. Greve, Aswin Verhoeven, Rico J. Derks, Martin Giera, Yanan Wang, Patrick C.N. Rensen. Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP. Atherosclerosis 2018; 275: 149 doi: 10.1016/j.atherosclerosis.2018.06.004
|
| 12 |
Takashi Yamaguchi, Katsunori Yoshida, Miki Murata, Kanehiko Suwa, Koichi Tsuneyama, Koichi Matsuzaki, Makoto Naganuma. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 23(11): 6270 doi: 10.3390/ijms23116270
|
| 13 |
Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier. Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments. Clinical Science 2020; 134(16): 2117 doi: 10.1042/CS20200022
|
| 14 |
Kyoko Tomita, Rohit Kohli, Brittany L. MacLaurin, Petra Hirsova, Qianqian Guo, Luz H. Gutierrez Sanchez, Harris A. Gelbard, Burns C. Blaxall, Samar H. Ibrahim. Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis. JCI Insight 2017; 2(15) doi: 10.1172/jci.insight.94488
|
| 15 |
Samar H Ibrahim, Petra Hirsova, Gregory J Gores. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut 2018; 67(5): 963 doi: 10.1136/gutjnl-2017-315691
|
| 16 |
Juan Du, Xuemei Cao, Junlin Diao, Qijuan Zhang, Chuan Peng, Jibin Li, Xiaoqiu Xiao. Neonatal overfeeding in mice aggravates the development of methionine and choline-deficient diet-induced steatohepatitis in adulthood. Genes & Diseases 2019; 6(1): 68 doi: 10.1016/j.gendis.2017.12.008
|
| 17 |
Guoqiang Fan, Yanfei Li, Jinglong Chen, Yibo Zong, Xiaojing Yang. DHA/AA alleviates LPS-induced Kupffer cells pyroptosis via GPR120 interaction with NLRP3 to inhibit inflammasome complexes assembly. Cell Death & Disease 2021; 12(1) doi: 10.1038/s41419-020-03347-3
|
| 18 |
Kyoko Tomita, Brittany L. Freeman, Steven F. Bronk, Nathan K. LeBrasseur, Thomas A. White, Petra Hirsova, Samar H. Ibrahim. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis. Scientific Reports 2016; 6(1) doi: 10.1038/srep28786
|
| 19 |
Haiou Li, Yunjiao Zhou, Haizhou Wang, Meng Zhang, Peishan Qiu, Mengna Zhang, Ruike Zhang, Qiu Zhao, Jing Liu. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01169
|
| 20 |
Elizabeth C. Stahl, Evan R. Delgado, Frances Alencastro, Samuel T. LoPresti, Patrick D. Wilkinson, Nairita Roy, Martin J. Haschak, Clint D. Skillen, Satdarshan P. Monga, Andrew W. Duncan, Bryan N. Brown. Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2. The American Journal of Pathology 2020; 190(2): 372 doi: 10.1016/j.ajpath.2019.10.016
|
| 21 |
Marie Lequoy, Elia Gigante, Jean-Pierre Couty, Christèle Desbois-Mouthon. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2019-0044
|
| 22 |
Rishi Sharma, Kevin Liaw, Anjali Sharma, Ambar Jimenez, Michelle Chang, Sebastian Salazar, Imaan Amlani, Sujatha Kannan, Rangaramanujam M. Kannan. Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma. Journal of Controlled Release 2021; 337: 179 doi: 10.1016/j.jconrel.2021.07.018
|
| 23 |
Xiaoyan Zhang, Jingxin Li, Tiancai Liu, Min Zhao, Baozhu Liang, Hong Chen, Zhen Zhang, Ihtisham Bukhari. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4369329
|
| 24 |
Dae Won Ma, Joohun Ha, Kyung Sik Yoon, Insug Kang, Tae Gyu Choi, Sung Soo Kim. Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Nutrients 2023; 15(9): 2068 doi: 10.3390/nu15092068
|
| 25 |
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. International Journal of Molecular Sciences 2019; 20(20): 5037 doi: 10.3390/ijms20205037
|
| 26 |
Niranjani Venkateswaran, Scott Weismiller, Karen Krok. Recurrent NASH Post-liver Transplant: Implications and Treatment. Current Hepatology Reports 2021; 20(4): 108 doi: 10.1007/s11901-021-00569-7
|
| 27 |
Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M. Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology 2018; 11: 175628481881150 doi: 10.1177/1756284818811508
|
| 28 |
Linlin Yao, Yuanyuan Wang, Jianbo Shi, Yanna Liu, Hao Guo, Xiaoxi Yang, Yaquan Liu, Junjie Ma, Danyang Li, Ziniu Wang, Zikang Li, Qian Luo, Jianjie Fu, Qinghua Zhang, Guangbo Qu, Yanxin Wang, Guibin Jiang. Toxicity of Tetrabromobisphenol A and Its Derivative in the Mouse Liver Following Oral Exposure at Environmentally Relevant Levels. Environmental Science & Technology 2021; 55(12): 8191 doi: 10.1021/acs.est.1c01726
|
| 29 |
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, Ariel E. Feldstein. Innate Immunity and Inflammation in NAFLD/NASH. Digestive Diseases and Sciences 2016; 61(5): 1294 doi: 10.1007/s10620-016-4049-x
|
| 30 |
Nicolas Lanthier, Nathalie Lin-Marq, Laura Rubbia-Brandt, Sophie Clément, Nicolas Goossens, Laurent Spahr. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-017-0541-2
|
| 31 |
Sine Kragh Petersen, Orsolya Bilkei‐Gorzo, Olivier Govaere, Anetta Härtlova. Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD). Scandinavian Journal of Immunology 2020; 92(5) doi: 10.1111/sji.12971
|
| 32 |
Chi Ma, Qianfei Zhang, Tim F. Greten. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes. The FEBS Journal 2018; 285(4): 752 doi: 10.1111/febs.14209
|
| 33 |
Zixiong Zhou, Jong Won Kim, Jing Zhao, Jing Qi, Seong Jin Choi, Chae Woong Lim, Moo-Yeol Lee, Kyuhong Lee, Bumseok Kim. Treatment of cigarette smoke extract and condensate differentially potentiates palmitic acid-induced lipotoxicity and steatohepatitis in vitro. Toxicology in Vitro 2018; 52: 33 doi: 10.1016/j.tiv.2018.05.017
|
| 34 |
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(7): 1745 doi: 10.3390/ijms20071745
|
| 35 |
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines 2021; 9(2): 184 doi: 10.3390/biomedicines9020184
|
| 36 |
Juan Zheng, Ting Chen, Xin Guo, James M. Ntambi, Chaodong Wu. Lipid Signaling and Metabolism. 2020; : 273 doi: 10.1016/B978-0-12-819404-1.00014-2
|
| 37 |
Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708978
|
| 38 |
Nicolas Lanthier, Nathalie Delzenne. Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?. Cells 2022; 11(17): 2718 doi: 10.3390/cells11172718
|
| 39 |
Komal Sodhi, Krithika Srikanthan, Perrine Goguet-Rubio, Alexandra Nichols, Amrita Mallick, Athar Nawab, Rebecca Martin, Preeya T. Shah, Muhammad Chaudhry, Saroj Sigdel, Mehiar El-Hamdani, Jiang Liu, Zijian Xie, Nader G. Abraham, Joseph I. Shapiro. RETRACTED ARTICLE: pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00306-5
|
| 40 |
Ozlem Kutlu, Humeyra Nur Kaleli, Ebru Ozer. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8543763
|
| 41 |
Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou, Yunxia Li. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic
Fatty Liver Disease: A Review on Molecular Mechanisms. Current Molecular Pharmacology 2022; 15(6): 846 doi: 10.2174/1874467215666211217120448
|
| 42 |
Zhongbo Liu, Jose Cordoba-Chacon, Rhonda D. Kineman, Bruce N. Cronstein, Radhika Muzumdar, Zhenwei Gong, Haim Werner, Shoshana Yakar. Growth Hormone Control of Hepatic Lipid Metabolism. Diabetes 2016; 65(12): 3598 doi: 10.2337/db16-0649
|
| 43 |
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, Olivier Govaere, Mathias Heikenwalder. From NASH to HCC: current concepts and future challenges. Nature Reviews Gastroenterology & Hepatology 2019; 16(7): 411 doi: 10.1038/s41575-019-0145-7
|
| 44 |
Sébastien Lepreux, Julien Villeneuve, Antoine Dewitte, Annie M. Bérard, Alexis Desmoulière, Jean Ripoche. CD40 signaling and hepatic steatosis: Unanticipated links. Clinics and Research in Hepatology and Gastroenterology 2017; 41(4): 357 doi: 10.1016/j.clinre.2016.11.002
|
| 45 |
Xue-Kai Wang, Zong-Gen Peng. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655557
|
| 46 |
Lindsey Devisscher, Xavier Verhelst, Isabelle Colle, Hans Van Vlierberghe, Anja Geerts. The role of macrophages in obesity-driven chronic liver disease. Journal of Leukocyte Biology 2016; 99(5): 693 doi: 10.1189/jlb.5RU0116-016R
|
| 47 |
Helk Oliver, Dekeryte Ruta, Dawn Thompson, Sarah Kamli-Salino, Sam Philip, Heather M. Wilson, Nimesh Mody, Mirela Delibegovic. Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04598-2
|
| 48 |
Guoqiang Fan, Yanfei Li, Yaxin Liu, Xiaoyi Suo, Yimin Jia, Xiaojing Yang. Gondoic acid alleviates LPS‑induced Kupffer cells inflammation by inhibiting ROS production and PKCθ/ERK/STAT3 signaling pathway. International Immunopharmacology 2022; 111: 109171 doi: 10.1016/j.intimp.2022.109171
|
| 49 |
Moumita Saha, Krishnendu Manna, Krishna Das Saha. Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model. Journal of Inflammation Research 2022; : 3235 doi: 10.2147/JIR.S343236
|